Inventor · disambiguated record
Philip M. Sass
Also filed as: SASS PHILIP M
58 granted patents·23 pending applications·417 citations·filing 2000–2017
99Inventor score
Top patents by PatentIndex Score
81 records- 0197US7592426B2Anti-mesothelin antibodiesMORPHOTEK INC·Filed 2006·Granted Sep 22, 2009·38 cites·14 claims
- 0295US9115197B2Anti-mesothelin antibodiesMORPHOTEK INC·Filed 2014·Granted Aug 25, 2015·15 cites·16 claims
- 0395US8206710B2Anti-mesothelin antibodiesEBEL WOLFGANG·Filed 2009·Granted Jun 26, 2012·29 cites·3 claims
- 0495US8124083B2Antibodies with immune effector activity and that internalize in folate receptor alpha-positive cellsGRASSO LUIGI·Filed 2009·Granted Feb 28, 2012·27 cites·7 claims
- 0595US6808894B1Methods for generating genetically altered antibody producing cell lines with improved antibody characteristicsMORPHOTEK INC·Filed 2000·Granted Oct 26, 2004·43 cites·21 claims
- 0694US7615372B2Antibodies with immune effector activity and that internalize in endosialin-positive cellsMORPHOTEK INC·Filed 2006·Granted Nov 10, 2009·12 cites·12 claims
- 0793US7741450B2Antibodies to GM-CSFMORPHOTEK INC·Filed 2007·Granted Jun 22, 2010·21 cites·6 claims
- 0892US8524237B2Antibodies with immune effector activity and that internalize in endosialin-positive cellsMORPHOTEK INC·Filed 2012·Granted Sep 3, 2013·6 cites·14 claims
- 0992US8318168B2Antigenic GM-CSF peptides and antibodies to GM-CSFSASS PHILIP M·Filed 2010·Granted Nov 27, 2012·18 cites·7 claims
- 1091US8278065B2Polynucleotides encoding anti-GD2 antibodiesNICOLAIDES NICHOLAS C·Filed 2009·Granted Oct 2, 2012·11 cites·28 claims
- 1189US9144614B2Antibodies with immune effector activity and that internalize in folate receptor alpha-positive cellsNICOLAIDES NICHOLAS C·Filed 2012·Granted Sep 29, 2015·5 cites·4 claims
- 1289US7807382B2Methods for inhibiting the binding of endosialin to ligandsMORPHOTEK INC·Filed 2008·Granted Oct 5, 2010·11 cites·8 claims
- 1388US8623364B2Antigenic GM-CSF peptides and antibodies to GM-CSFSASS PHILIP M·Filed 2012·Granted Jan 7, 2014·9 cites·11 claims
- 1488US8507657B2Anti-GD2 antibodiesNICOLAIDES NICHOLAS C·Filed 2012·Granted Aug 13, 2013·10 cites·6 claims
- 1588US8481703B2Anti-mesothelin antibodiesEBEL WOLFGANG·Filed 2012·Granted Jul 9, 2013·6 cites·9 claims
- 1688US6825038B2Method for generating hypermutable organismsUNIV JOHNS HOPKINS·Filed 2001·Granted Nov 30, 2004·14 cites·7 claims
- 1788US6656736B2Methods for generating hypermutable yeastUNIV JOHNS HOPKINS·Filed 2001·Granted Dec 2, 2003·13 cites·42 claims
- 1887US8236932B2High affinity antibodies that neutralize Staphylococcus enterotoxin BSASS PHILIP M·Filed 2008·Granted Aug 7, 2012·8 cites·24 claims
- 1987US6921666B2Methods for generating hypermutable yeastMORPHOTEK·Filed 2003·Granted Jul 26, 2005·17 cites·18 claims
- 2087US6576468B1Methods for obtaining microbe-resistant mammalian cells from hypermutable mammalian cellsMORPHOTEK INC·Filed 2000·Granted Jun 10, 2003·14 cites·18 claims
- 2186US8895704B2High affinity antibodies that neutralize Staphylococcus enterotoxin BMORPHOTEK INC·Filed 2013·Granted Nov 25, 2014·6 cites·6 claims
- 2286US8889846B2High affinity antibodies that neutralize Staphylococcus enterotoxin BSASS PHILIP M·Filed 2012·Granted Nov 18, 2014·6 cites·17 claims
- 2385US9650440B2Monoclonal antibodies that specifically block biological activity of a tumor antigenMORPHOTEK INC·Filed 2013·Granted May 16, 2017·5 cites·16 claims
- 2485US6737268B1Method for generating genetically altered antigensMORPHOTEK INC·Filed 2000·Granted May 18, 2004·10 cites·10 claims
- 2584US9359428B2High affinity antibodies that neutralize Staphylococcus enterotoxin BMORPHOTEK INC·Filed 2014·Granted Jun 7, 2016·4 cites·4 claims
- 2684US7026119B2Methods for generating hypermutable microbesUNIV JOHNS HOPKINS·Filed 2001·Granted Apr 11, 2006·8 cites·15 claims
- 2783US7235643B2Antibodies and methods for generating genetically altered antibodies with high affinityMORPHOTEK INC·Filed 2002·Granted Jun 26, 2007·7 cites·5 claims
- 2882US9868780B2High affinity antibodies that neutralize Staphylococcus enterotoxin BMORPHOTEK INC·Filed 2016·Granted Jan 16, 2018·2 cites·4 claims
- 2982US7671179B2Antibodies and methods for generating genetically altered antibodies with high affinityMORPHOTEK INC·Filed 2007·Granted Mar 2, 2010·3 cites·5 claims
- 3082US7604994B2Genetically altered antibody-producing cell lines with improved antibody characteristicsMORPHOTEK INC·Filed 2004·Granted Oct 20, 2009·5 cites·29 claims
- 3181US8389691B2Antibodies with immune effector activity and that internalize in endosialin-positive cellsNICOLAIDES NICHOLAS C·Filed 2009·Granted Mar 5, 2013·3 cites·11 claims
- 3279US7223598B2Methods for isolating novel antimicrobial agents from hypermutable mammalian cellsMORPHOTEK INC·Filed 2005·Granted May 29, 2007·2 cites·7 claims
- 3378US9624297B2Monoclonal antibodies that specifically block biological activity of a tumor antigenGRASSO LUIGI·Filed 2009·Granted Apr 18, 2017·2 cites·42 claims
- 3478US7759121B2Methods for generating hypermutable yeastUNIV JOHNS HOPKINS·Filed 2007·Granted Jul 20, 2010·1 cites·22 claims
- 3578US7754450B2Methods of generating high-production of antibodies from hybridomas created by in vitro immunizationMORPHOTEK INC·Filed 2003·Granted Jul 13, 2010·5 cites·45 claims
- 3678US7514216B2Methods for generating hypermutable yeastUNIV JOHNS HOPKINS·Filed 2005·Granted Apr 7, 2009·1 cites·16 claims
- 3777US8658173B2Anti-mesothelin antibodiesMORPHOTEK INC·Filed 2013·Granted Feb 25, 2014·1 cites·11 claims
- 3877US7704689B2Method for generating hypermutable plantsUNIV JOHNS HOPKINS·Filed 2005·Granted Apr 27, 2010·1 cites·12 claims
- 3977US7695969B2Methods for generating hypermutable microbesUNIV JOHNS HOPKINS·Filed 2006·Granted Apr 13, 2010·1 cites·21 claims
- 4077US6982169B2Chemical inhibitors of mismatch repairMORPHOTEK INC·Filed 2001·Granted Jan 3, 2006·4 cites·29 claims
- 4176US9522195B2Antibodies with immune effector activity and that internalize in folate receptor alpha-positive cellsMORPHOTEK INC·Filed 2015·Granted Dec 20, 2016·1 cites·12 claims
- 4275US7319036B2Method for generating hypermutable organismsUNIV JOHNS HOPKINS MED·Filed 2004·Granted Jan 15, 2008·2 cites·17 claims
- 4374US8895000B2Methods for inhibiting the binding of endosialin to ligandsZHOU YUHONG·Filed 2010·Granted Nov 25, 2014·3 cites·28 claims
- 4473US9505842B2Methods for inhibiting the binding of endosialin to ligandsMORPHOTEK INC·Filed 2014·Granted Nov 29, 2016·1 cites·5 claims
- 4572US7638334B2Method for generating engineered cells by homologously recombining segments having increased degeneracyMORPHOTEK INC·Filed 2003·Granted Dec 29, 2009·3 cites·46 claims
- 4669US2006239910A1Antibodies with immune effector activity and that internalize in folate receptor alpha-positive cellsMORPHOTEK INC·Filed 2006·Application pending·0 cites
- 4767US7892832B2Methods for generating hypermutable microbesUNIV JOHNS HOPKINS·Filed 2007·Granted Feb 22, 2011·0 cites·3 claims
- 4866US10364284B2High affinity antibodies that neutralize Staphylococcus enterotoxin BEISAI INC·Filed 2017·Granted Jul 30, 2019·0 cites·4 claims
- 4964US9422367B2Antigenic GM-CSF peptides and antibodies to GM-CSFMORPHOTEK INC·Filed 2013·Granted Aug 23, 2016·0 cites·20 claims
- 5064US8956832B2Cells expressing anti-GD2 antibodies and methods related theretoMORPHOTEK INC·Filed 2013·Granted Feb 17, 2015·0 cites·4 claims
Showing the top 50 of 81 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Philip M. Sass files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →